Proteome Sciences PLC (PRM) — Cash Flow-to-Debt Ratio
Proteome Sciences PLC (PRM) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of GBX851.00K could theoretically repay 0% of its total liabilities (GBX17.79 Million) in one year. See financial agility of Proteome Sciences PLC to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Proteome Sciences PLC Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for Proteome Sciences PLC across 31 annual periods. For the full cash flow conversion analysis, see Proteome Sciences PLC (PRM) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Proteome Sciences PLC (1994–2025)
Year-by-year debt coverage analysis for Proteome Sciences PLC. Check PRM cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | GBX-46.00K | GBX17.79 Million | ▲ +95.1% |
| 2024 | -0.05x | GBX-826.00K | GBX15.72 Million | ▼ -58.6% |
| 2023 | -0.03x | GBX-481.00K | GBX14.52 Million | ▼ -2235443.5% |
| 2022 | 0.00x | GBX2.14 Million | GBX1.44 Trillion | ▲ +145.5% |
| 2021 | 0.00x | GBX793.00K | GBX1.31 Trillion | ▼ -51.1% |
| 2020 | 0.00x | GBX1.58 Million | GBX1.28 Trillion | ▲ +100.0% |
| 2019 | -0.02x | GBX-21.45 Billion | GBX1.07 Trillion | ▼ -44.5% |
| 2018 | -0.01x | GBX-14.78 Billion | GBX1.07 Trillion | ▼ -126.6% |
| 2017 | 0.05x | GBX55.47 Billion | GBX1.07 Trillion | ▲ +119.5% |
| 2016 | -0.27x | GBX-31.70 Billion | GBX119.08 Billion | ▼ -701.7% |
| 2015 | 0.04x | GBX46.63 Billion | GBX1.05 Trillion | ▲ +1012.0% |
| 2014 | 0.00x | GBX-6.27 Billion | GBX1.29 Trillion | ▲ +46.3% |
| 2013 | -0.01x | GBX-11.55 Billion | GBX1.28 Trillion | ▲ +97.9% |
| 2012 | -0.43x | GBX-3.35 Million | GBX7.72 Million | ▲ +36.0% |
| 2011 | -0.68x | GBX-5.17 Million | GBX7.61 Million | ▼ -242.1% |
| 2010 | 0.48x | GBX4.00 Million | GBX8.38 Million | ▲ +348.2% |
| 2009 | -0.19x | GBX-2.97 Million | GBX15.44 Million | ▲ +43.6% |
| 2008 | -0.34x | GBX-4.12 Million | GBX12.07 Million | ▲ +26.6% |
| 2007 | -0.47x | GBX-4.09 Million | GBX8.80 Million | ▲ +50.9% |
| 2006 | -0.95x | GBX-3.61 Million | GBX3.81 Million | ▲ +65.8% |
| 2005 | -2.77x | GBX-4.77 Million | GBX1.72 Million | ▼ -12.9% |
| 2004 | -2.45x | GBX-3.77 Million | GBX1.54 Million | ▼ -29.8% |
| 2003 | -1.89x | GBX-4.88 Million | GBX2.58 Million | ▼ -14.4% |
| 2002 | -1.65x | GBX-3.27 Million | GBX1.98 Million | ▼ -31.5% |
| 2001 | -1.26x | GBX-1.55 Million | GBX1.24 Million | ▼ -73.3% |
| 2000 | -0.72x | GBX-1.14 Million | GBX1.57 Million | ▲ +59.7% |
| 1999 | -1.80x | GBX-1.25 Million | GBX697.00K | ▼ -0.5% |
| 1998 | -1.79x | GBX-1.54 Million | GBX862.00K | ▲ +23.3% |
| 1997 | -2.33x | GBX-1.29 Million | GBX551.00K | ▲ +61.1% |
| 1996 | -6.01x | GBX-1.71 Million | GBX285.00K | ▼ -410.9% |
| 1994 | -1.18x | GBX-809.00K | GBX688.00K | — |